Switch activation of PI-PLC downstream signals in activated macrophages with wortmannin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 6, 2007, Pages 869-879

  Liu, Der Zen ^a   Liang, Hong Jen ^b   Chen, Chien Ho ^c   Lin, Shyr Yi ^c   Zhong, Wen Bin ^d   Ho, Feng Ming ^e   Hou, Wen Chi ^a   Lo, Jui Lien ^c   Ho, Yuan Soon ^c   Lin, Pei Jung ^c   Hung, Ling Fang ^c   Liang, Yu Chih ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Departments of Medicine   (Taiwan)

^e TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Inducible nitric oxide synthase; Lipopolysaccharide; Phosphatidylinositol 3 kinase; Phosphoinositide specific phospholipase C; Wortmannin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; PHOSPHATE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL (4,5) BISPHOSPHATE; PHOSPHOLIPASE; PROTEIN P110; PROTEIN P85; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CELL LINE; DIGLYCERIDES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INOSITOL 1,4,5-TRISPHOSPHATE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHODIESTERASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTOR AP-1;

EID: 34249682802     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.03.018     Document Type: Article

References (38)

1. Adams D.O., and Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2 (1984) 283-318
2. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
3. Mayer B., and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22 (1997) 477-481
4. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500 (2004) 255-266
5. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., and Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100 (2003) 171-194
6. Ye R.D. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J. Leukocyte Biol. 70 (2001) 839-848
7. Yin H.L., and Janmey P.A. Phosphoinositide regulation of the actin cytoskeleton. Annu. Rev. Physiol. 65 (2003) 761-789
8. Jones D.R., and Divecha N. Linking lipids to chromatin. Curr. Opin. Genet. Dev. 14 (2004) 196-202
9. Boronenkov I.V., Loijens J.C., Umeda M., and Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol. Biol. Cell 9 (1998) 3547-3560
10. Halstead J.R., Jalink K., and Divecha N. An emerging role for PtdIns(4,5)P2-mediated signalling in human disease. Trends Pharmacol. Sci. 26 (2005) 654-660
11. Irvine R.F., and Schell M.J. Back in the water: the return of the inositol phosphates. Nat. Rev., Mol. Cell Biol. 2 (2001) 327-338
12. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev., Cancer 2 (2002) 489-501
13. Wymann M.P., Zvelebil M., and Laffargue M. Phosphoinositide 3-kinase signalling-Which way to target?. Trends Pharmacol. Sci. 24 (2003) 366-376
14. Scheid M.P., Huber M., Damen J.F., Hughes M., Kang V., Neilsen P., Prestwich G.D., Krystal G., and Duronio V. Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J. Biol. Chem. 277 (2002) 9027-9035
15. Park Y.C., Lee C.H., Kang H.S., Chung H.T., and Kim H.D. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 240 (1997) 692-696
16. Guha M., and Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277 (2002) 32124-32132
17. Monick M.M., Robeff P.K., Butler N.S., Flaherty D.M., Carter A.B., Peterson M.W., and Hunninghake G.W. Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA. J. Biol. Chem. 277 (2002) 32992-33000
18. Pahan K., Raymond J.R., and Singh I. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J. Biol. Chem. 274 (1999) 7528-7536
19. Teshima S., Nakanishi H., Nishizawa M., Kitagawa K., Kaibori M., Yamada M., Habara K., Kwon A.H., Kamiyama Y., Ito S., and Okumura T. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J. Hepatol. 40 (2004) 616-623
20. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin Jr. A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276 (2001) 18934-18940
21. Yamaguchi K., Lee S.H., Kim J.S., Wimalasena J., Kitajima S., and Baek S.J. Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway. Cancer Res. 66 (2006) 2376-2384
22. Monick M.M., Carter A.B., Robeff P.K., Flaherty D.M., Peterson M.W., and Hunninghake G.W. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 166 (2001) 2470-4713
23. Chen C.C., Wang J.K., and Lin S.B. Antisense oligonucleotides targeting protein kinase C-alpha,-beta I, or-delta but not-eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. J. Immunol. 161 (1998) 6206-6214
24. Chen C.H., Sheu M.T., Chen T.F., Wang Y.C., Hou W.C., Liu D.Z., Chung T.C., and Liang Y.C. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem. Pharmacol. 72 (2006) 1001-1009
25. Way T.D., Kao M.C., and Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279 (2004) 4479-4489
26. Lowenestein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., and Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9730-9734
27. Liang Y.C., Tsai D.C., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase through peroxisome proliferator-activated receptor-γ by apigenin and related-flavonoids in macrophages. FEBS Lett. 496 (2001) 12-18
28. Shinji H., Akagawa K.S., Tsuji M., Maeda M., Yamada R., Matsuura K., Yamamoto S., and Yoshida T. Lipopolysaccharide-induced biphasic inositol 1,4,5-trisphosphate response and tyrosine phosphorylation of 140-kilodalton protein in mouse peritoneal macrophages. J. Immunol. 158 (1997) 1370-1376
29. Kudoh A., Katagai H., and Takazawa T. Ketamine inhibits endotoxin-induced inositol 1,4,5-triphosphate in rat ventricular cardiomyocytes. Int. Care Med. 29 (2003) 1812-1817
30. Tolloczko B., Turkewitsch P., Al-Chalabi M., and Martin J.G. LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition. J. Pharmacol. Exp. Ther. 311 (2004) 787-793
31. Pasapera Limon A.M., Herrera-Munoz J., Gutierrez-Sagal R., and Ulloa-Aguirre A. The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17h-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene. Mol. Cell Endocrinol. 200 (2003) 199-202
32. Choi E.K., Park H.J., Ma J.S., Lee H.C., Kang H.C., Kim B.G., and Kang I.C. LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism. FEBS Lett. 559 (2004) 141-144
33. Zhou X., Yang W., and Li J. Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappa B activation, inducible nitric oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J. Biol. Chem. 281 (2006) 31337-31347
34. Kim Y., Moon J.S., Lee K.S., Park S.Y., Cheong J., Kang H.S., Lee H.Y., and Kim H.D. Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-kappaB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem. Biophys. Res. Commun. 314 (2004) 695-703
35. Denlinger L.C., Fisette P.L., Garis K.A., Kwon G., Vazquez-Torres A., Simon A.D., Nguyen B., Proctor R.A., Bertics P.J., and Corbett J.A. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J. Biol. Chem. 271 (1996) 337-342
36. Geng Y., and Lotz M. Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability. J. Cell Biol. 129 (1995) 1651-1657
37. Bereta M., Bereta J., Georgoff I., Coffman F.D., Cohen S., and Cohen M.C. Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells. Exp. Cell Res. 212 (1994) 230-242
38. Osawa Y., Banno Y., Nagaki M., Brenner D.A., Naiki T., Nozawa Y., Nakashima S., and Moriwaki H. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J. Immunol. 167 (2001) 173-180